Comments
Loading...
Kaleido Biosciences (OTC:KLDO) Stock, Earnings Estimates, EPS, And Revenue
Kaleido Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 1
EPS
$-0.540
Quarterly Revenue
$104.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.10M
Analyze the earnings history of Kaleido Biosciences using advanced sorting and filters.
Data brought to you by Benzinga APIs
Kaleido Biosciences (KLDO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-01 | $-0.54 | $-0.54 | 0.00 % |
| Q2 | 2021-08-11 | $-0.56 | $-0.57 | 1.75 % |
| Q1 | 2021-05-04 | $-0.58 | $-0.59 | 1.69 % |
| Q2 | 2020-08-04 | $-0.59 | $-0.59 | 0.00 % |
Kaleido Biosciences (KLDO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-01 | $104.00K | $170.00K | -38.8 % |
| Q2 | 2021-08-11 | $211.00K | $110.00K | 91.8 % |
FAQ
When is Kaleido Biosciences (OTCEM:KLDO) reporting earnings?
Kaleido Biosciences (KLDO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 1, 2021 for Q3.
What were the latest earnings per share (EPS) for Kaleido Biosciences (OTCEM:KLDO)?
Kaleido Biosciences (KLDO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 1, 2021 for Q3 and the Actual EPS was $-0.54, which hit the estimate of $-0.54.
What were Kaleido Biosciences’s (OTCEM:KLDO) revenues?
Kaleido Biosciences (KLDO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 1, 2021 for Q3 and the Actual Revenue was $104K, which missed the estimate of $170K.
Browse earnings estimates, EPS, and revenue on all stocks.